Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Ascites (Phase 2)

Bile Duct Neoplasms (Phase 2)

Brain Neoplasms (Phase 2)

Carcinoma (Phase 4)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 1)

Carcinoma, Squamous Cell (Phase 4)

Cerebral Infarction (Phase 3)

Cholangiocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 3)

Esophageal Neoplasms (Phase 2)

Essential Hypertension (Phase 4)

Gallbladder Neoplasms (Phase 2)

Herpesviridae Infections (Phase 3)

Hypertension (Phase 4)

Infections (Phase 3)

Influenza, Human (Phase 3)

Ischemia (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Liver Neoplasms (Phase 1)

Lung Neoplasms (Phase 4)

Lymphoma (Phase 2)

Lymphoma, T-Cell (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 3)

Nasopharyngeal Carcinoma (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 3)

Neoplasms, Second Primary (Phase 2)

Neurilemmoma (Phase 2)

Neurofibroma (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Neurofibromatosis 2 (Phase 2)

Neuroma, Acoustic (Phase 2)

Osteosarcoma (Phase 2)

Ovarian Neoplasms (Phase 1)

Pleural Effusion (Phase 2)

Pleural Effusion, Malignant (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Stomach Neoplasms (Phase 2)

Stroke (Phase 3)

Virus Diseases (Phase 3)